Abstract

Breast cancer survivors are becoming increasingly concerned about cardiovascular disease (CVD). However, it is still uncertain how much of a burden this comorbidity has on this group compared to the overall population and its temporal pattern. Compared to women without breast cancer, breast cancer survivors are more likely to die from CVDs, and this increased risk becomes apparent about seven years after diagnosis. To lessen the excessive burden of CVD in this vulnerable population, efforts should be made to discover risk factors and therapies that can be used in this limited time frame.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call